https://www.exai.bio https://www.exai.bio/careers https://www.exai.bio/contact https://www.exai.bio/privacy-policy https://www.exai.bio/terms-of-use https://www.exai.bio/partnerships https://www.exai.bio/publications/detection-of-early-stage-cancers-using-circulating-orphan-non-coding-rnas-in-blood https://www.exai.bio/publications/ai-based-early-detection-and-subtyping-of-non-small-cell-lung-cancer-from-blood-samples-using-orphan-non-coding-rnas https://www.exai.bio/publications/transcriptome-wide-co-expression-of-small-non-coding-rnas-and-genes-in-cancer https://www.exai.bio/publications/blood-based-early-detection-of-non-small-cell-lung-cancer-using-orphan-noncoding-rnas https://www.exai.bio/publications/early-stage-breast-cancer-detection-using-orphan-noncoding-rnas https://www.exai.bio/publications/serum-based-colorectal-cancer-detection-using-orphan-noncoding-rnas https://www.exai.bio/publications/discovery-and-validation-of-orphan-noncoding-rna-profiles-across-multiple-cancers-in-tcga-and-two-independent-cohorts https://www.exai.bio/publications/tumor-released-circulating-orphan-non-coding-rnas-reflect-treatment-response-and-survival-in-breast-cancer https://www.exai.bio/publications/cancer-cells-exploit-an-orphan-rna-to-drive-metastatic-progression https://www.exai.bio/publications/cell-free-orphan-noncoding-rnas-and-ai-enable-early-detection-of-invasive-breast-and-ductal-carcinoma-in-situ https://www.exai.bio/publications/aacr-2024-ukansas https://www.exai.bio/publications/beyond-detection-ai-based-classification-of-breast-cancer-invasiveness-using-cell-free-orphan-non-coding-rnas https://www.exai.bio/about/leadership https://www.exai.bio/about/advisors https://www.exai.bio/about/board-and-investors https://www.exai.bio/about/our-history https://www.exai.bio/science/our-advantage https://www.exai.bio/science/our-performance https://www.exai.bio/news https://www.exai.bio/publications https://www.exai.bio/publications/cell-free-orphan-non-coding-rnas-secreted-by-breast-cancers-are-not-confounded-by-breast-tissue-density https://www.exai.bio/publications/harnessing-cell-free-orphan-non-coding-rnas-as-a-predictive-measure-of-long-term-survival-in-neoadjuvant-breast-cancer-therapy https://www.exai.bio/publications/predicting-tumor-er-and-her2-status-using-a-cell-free-rna-liquid-biopsy-assay https://www.exai.bio/publications/deep-generative-ai-models-analyzing-circulating-orphan-non-coding-rnas-enable-detection-of-early-stage-lung-cancer https://www.exai.bio/publications/detection-of-early-stage-colorectal-cancer-using-cell-free-oncrna-biomarkers-and-ai https://www.exai.bio/publications/early-stage-breast-cancer-detection-with-a-plasma-cell-free-rna-and-ai-based-liquid-biopsy-platform https://www.exai.bio/news/exai-bio-and-quantum-leap-healthcare-collaborative-announce-expanded-participation-in-i-spy-2-trial-to-advance-exais-novel-rna-based-liquid-biopsy-platform-in-breast-cancer https://www.exai.bio/news/exai-bio-announces-appointments-of-emi-zychlinsky-and-seema-singh-bhan-to-its-executive-leadership-team https://www.exai.bio/news/exai-bio-announces-publication-in-nature-communications-highlighting-its-generative-ai-liquid-biopsy-platform https://www.exai.bio/news/exai-bio-appoints-dave-daly-as-chief-executive-officer https://www.exai.bio/news/exai-bio-appoints-oncology-leader-and-former-american-cancer-society-ceo-karen-e-knudsen-mba-phd-to-its-board-of-directors https://www.exai.bio/news/exai-bio-demonstrates-its-unique-rna-based-liquid-biopsy-strategy-for-early-detection-and-monitoring-of-multiple-cancers https://www.exai.bio/news/exai-bio-presents-data-at-the-2023-san-antonio-breast-cancer-symposium https://www.exai.bio/news/exai-bio-presents-data-demonstrating-that-its-novel-rna-based-liquid-biopsy-platform-has-potential-for-early-detection-and-monitoring-of-colorectal-cancer https://www.exai.bio/news/exai-bio-presents-data-further-validating-its-liquid-biopsy-platform-at-the-2023-world-conference-on-lung-cancer https://www.exai.bio/news/exai-bio-presents-new-multi-cancer-early-detection-data-at-the-american-society-of-clinical-oncology-asco-2023-annual-meeting https://www.exai.bio/news/exai-bio-secures-67-5-million-series-a https://www.exai.bio/news/exai-bio-to-present-new-breast-cancer-data-at-the-american-association-for-cancer-research-aacr-2024-annual-meeting https://www.exai.bio/news/exai-bio-to-present-new-non-small-cell-lung-cancer-early-detection-data-at-the-american-association-for-cancer-research-aacr-2023-annual-meeting https://www.exai.bio/news/exai-bios-rna-based-liquid-biopsy-platform-delivers-promising-data-on-detecting-breast-cancer-at-its-earliest-stages https://www.exai.bio/team/alex-parker https://www.exai.bio/team/anna-hartwig https://www.exai.bio/team/babak-alipanahi https://www.exai.bio/team/carolyn-wang https://www.exai.bio/team/david-shulkin https://www.exai.bio/team/dusan-perovic https://www.exai.bio/team/emir-sandhu https://www.exai.bio/team/fereydoun-hormozdiari https://www.exai.bio/team/hani-goodarzi https://www.exai.bio/team/howard-chang https://www.exai.bio/team/james-zou https://www.exai.bio/team/kevan-shokat https://www.exai.bio/team/laura-van-t-veer https://www.exai.bio/team/lisa-fish https://www.exai.bio/team/michael-multhaup https://www.exai.bio/team/mike-pellini https://www.exai.bio/team/olivier-elemento https://www.exai.bio/team/raaj-trivedi https://www.exai.bio/team/robert-gentleman https://www.exai.bio/team/robert-warren https://www.exai.bio/team/seema-singh-bhan https://www.exai.bio/team/stephen-klasko https://www.exai.bio/team/steve-kafka https://www.exai.bio/about/board/emir-sandhu https://www.exai.bio/about/board/hani-goodarzi https://www.exai.bio/about/board/karen-e-knudsen https://www.exai.bio/about/board/michael-nall https://www.exai.bio/about/board/mike-pellini https://www.exai.bio/about/board/steve-kafka https://www.exai.bio/about/advisors/david-shulkin https://www.exai.bio/about/advisors/howard-chang https://www.exai.bio/about/advisors/james-zou https://www.exai.bio/about/advisors/kevan-shokat https://www.exai.bio/about/advisors/laura-van-t-veer https://www.exai.bio/about/advisors/olivier-elemento https://www.exai.bio/about/advisors/robert-gentleman https://www.exai.bio/about/advisors/robert-warren https://www.exai.bio/about/advisors/shelley-hwang https://www.exai.bio/about/advisors/stephen-klasko https://www.exai.bio/about/advisors/wendie-berg https://www.exai.bio/about/leadership/babak-alipanahi https://www.exai.bio/about/leadership/kim-brown https://www.exai.bio/about/leadership/lee-schwartzberg https://www.exai.bio/about/leadership/michael-nall https://www.exai.bio/about/leadership/raaj-trivedi https://www.exai.bio/about/leadership/seema-singh-bhan https://www.exai.bio/careers/member-of-computational-team